187 related articles for article (PubMed ID: 37216093)
1. Pancreas-derived DPP4 is not essential for glucose homeostasis under metabolic stress.
Fadzeyeva E; Locatelli CAA; Trzaskalski NA; Nguyen MA; Capozzi ME; Vulesevic B; Morrow NM; Ghorbani P; Hanson AA; Lorenzen-Schmidt I; Doyle MA; Seymour R; Varin EM; Fullerton MD; Campbell JE; Mulvihill EE
iScience; 2023 May; 26(5):106748. PubMed ID: 37216093
[TBL] [Abstract][Full Text] [Related]
2. Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis.
Mulvihill EE; Varin EM; Gladanac B; Campbell JE; Ussher JR; Baggio LL; Yusta B; Ayala J; Burmeister MA; Matthews D; Bang KWA; Ayala JE; Drucker DJ
Cell Metab; 2017 Jan; 25(1):152-165. PubMed ID: 27839908
[TBL] [Abstract][Full Text] [Related]
3. The prostaglandin E
Neuman JC; Reuter A; Carbajal KA; Schaid MD; Kelly G; Connors K; Kaiser C; Krause J; Hurley LD; Olvera A; Davis DB; Wisinski JA; Gannon M; Kimple ME
Am J Physiol Endocrinol Metab; 2024 May; 326(5):E567-E576. PubMed ID: 38477664
[TBL] [Abstract][Full Text] [Related]
4. DPP4 deletion in adipose tissue improves hepatic insulin sensitivity in diet-induced obesity.
Romacho T; Sell H; Indrakusuma I; Roehrborn D; Castañeda TR; Jelenik T; Markgraf D; Hartwig S; Weiss J; Al-Hasani H; Roden M; Eckel J
Am J Physiol Endocrinol Metab; 2020 May; 318(5):E590-E599. PubMed ID: 31891536
[TBL] [Abstract][Full Text] [Related]
5. Hepatic role in an early glucose-lowering effect by a novel dipeptidyl peptidase 4 inhibitor, evogliptin, in a rodent model of type 2 diabetes.
Kim TH; Kim MK; Cheong YH; Chae YN; Lee Y; Ka SO; Jung IH; Shin CY; Bae EJ; Son MH
Eur J Pharmacol; 2016 Jan; 771():65-76. PubMed ID: 26621343
[TBL] [Abstract][Full Text] [Related]
6. Incretin receptors for glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide are essential for the sustained metabolic actions of vildagliptin in mice.
Flock G; Baggio LL; Longuet C; Drucker DJ
Diabetes; 2007 Dec; 56(12):3006-13. PubMed ID: 17717280
[TBL] [Abstract][Full Text] [Related]
7. Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model.
Omar BA; Vikman J; Winzell MS; Voss U; Ekblad E; Foley JE; Ahrén B
Diabetologia; 2013 Aug; 56(8):1752-60. PubMed ID: 23636640
[TBL] [Abstract][Full Text] [Related]
8. TCF7 is not essential for glucose homeostasis in mice.
Kaur KD; Wong CK; Baggio LL; Beaudry JL; Fuchs S; Panaro BL; Matthews D; Cao X; Drucker DJ
Mol Metab; 2021 Jun; 48():101213. PubMed ID: 33741532
[TBL] [Abstract][Full Text] [Related]
9. Deletion of Ascl1 in pancreatic β-cells improves insulin secretion, promotes parasympathetic innervation, and attenuates dedifferentiation during metabolic stress.
Osipovich AB; Zhou FY; Chong JJ; Trinh LT; Cottam MA; Shrestha S; Cartailler JP; Magnuson MA
Mol Metab; 2023 Dec; 78():101811. PubMed ID: 37769990
[TBL] [Abstract][Full Text] [Related]
10. β-Cell Knockout of SENP1 Reduces Responses to Incretins and Worsens Oral Glucose Tolerance in High-Fat Diet-Fed Mice.
Lin H; Smith N; Spigelman AF; Suzuki K; Ferdaoussi M; Alghamdi TA; Lewandowski SL; Jin Y; Bautista A; Wang YW; Manning Fox JE; Merrins MJ; Buteau J; MacDonald PE
Diabetes; 2021 Nov; 70(11):2626-2638. PubMed ID: 34462260
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase inhibitor therapy in type 2 diabetes: Control of the incretin axis and regulation of postprandial glucose and lipid metabolism.
Mulvihill EE
Peptides; 2018 Feb; 100():158-164. PubMed ID: 29412815
[TBL] [Abstract][Full Text] [Related]
13. The dual DPP4 inhibitor and GPR119 agonist HBK001 regulates glycemic control and beta cell function ex and in vivo.
Huan Y; Jiang Q; Li G; Bai G; Zhou T; Liu S; Li C; Liu Q; Sun S; Yang M; Guo N; Wang X; Wang S; Liu Y; Wang G; Huang H; Shen Z
Sci Rep; 2017 Jun; 7(1):4351. PubMed ID: 28659588
[TBL] [Abstract][Full Text] [Related]
14. Agonist-independent Gα
Schaid MD; Green CL; Peter DC; Gallagher SJ; Guthery E; Carbajal KA; Harrington JM; Kelly GM; Reuter A; Wehner ML; Brill AL; Neuman JC; Lamming DW; Kimple ME
J Biol Chem; 2021; 296():100056. PubMed ID: 33172888
[TBL] [Abstract][Full Text] [Related]
15. Taurine supplementation prevents morpho-physiological alterations in high-fat diet mice pancreatic β-cells.
Ribeiro RA; Santos-Silva JC; Vettorazzi JF; Cotrim BB; Mobiolli DD; Boschero AC; Carneiro EM
Amino Acids; 2012 Oct; 43(4):1791-801. PubMed ID: 22418865
[TBL] [Abstract][Full Text] [Related]
16. Activation of ACE2/angiotensin (1-7) attenuates pancreatic β cell dedifferentiation in a high-fat-diet mouse model.
Xuan X; Gao F; Ma X; Huang C; Wang Y; Deng H; Wang S; Li W; Yuan L
Metabolism; 2018 Apr; 81():83-96. PubMed ID: 29225087
[TBL] [Abstract][Full Text] [Related]
17. SGLT2 and DPP4 inhibitors improve Alzheimer's disease-like pathology and cognitive function through distinct mechanisms in a T2D-AD mouse model.
Sim AY; Choi DH; Kim JY; Kim ER; Goh AR; Lee YH; Lee JE
Biomed Pharmacother; 2023 Dec; 168():115755. PubMed ID: 37871560
[TBL] [Abstract][Full Text] [Related]
18. Altered dipeptidyl peptidase-4 activity during the progression of hyperinsulinemic obesity and islet atrophy in spontaneously late-stage type 2 diabetic rats.
Kirino Y; Sato Y; Kamimoto T; Kawazoe K; Minakuchi K
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E372-9. PubMed ID: 21139073
[TBL] [Abstract][Full Text] [Related]
19. Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice.
Liu X; Harada N; Yamane S; Kitajima L; Uchida S; Hamasaki A; Mukai E; Toyoda K; Yamada C; Yamada Y; Seino Y; Inagaki N
Life Sci; 2009 Jun; 84(25-26):876-81. PubMed ID: 19358859
[TBL] [Abstract][Full Text] [Related]
20. High-fat diet-induced glucose dysregulation is independent of changes in islet ACE2 in mice.
Chodavarapu H; Chhabra KH; Xia H; Shenoy V; Yue X; Lazartigues E
Am J Physiol Regul Integr Comp Physiol; 2016 Dec; 311(6):R1223-R1233. PubMed ID: 27806985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
